RPL3L

Chr 16AR

ribosomal protein L3 like

Also known as: CMD2D

This protein is a heart- and skeletal muscle-specific ribosomal component that replaces the standard RPL3 paralog in striated muscle cells and regulates muscle function by inhibiting myotube growth. Mutations cause autosomal recessive dilated cardiomyopathy, primarily affecting cardiac muscle with potential involvement of skeletal muscle given the protein's tissue distribution. The gene shows low constraint against loss-of-function variants, consistent with its tissue-restricted expression pattern.

OMIMResearchSummary from RefSeq, OMIM, UniProt
ARLOEUF 1.611 OMIM phenotype
Clinical SummaryRPL3L
🧬
Gene-Disease Validity (ClinGen)
cardiomyopathy, dilated, 2D · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.61LOEUF
pLI 0.000
Z-score -0.53
OE 1.13 (0.811.61)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.69Z-score
OE missense 1.12 (1.021.23)
301 obs / 269.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.13 (0.811.61)
00.351.4
Missense OE1.12 (1.021.23)
00.61.4
Synonymous OE1.31
01.21.6
LoF obs/exp: 22 / 19.5Missense obs/exp: 301 / 269.3Syn Z: -2.58

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

RPL3L · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →